Helicobacter pylori CagA and VacA genotypes and gastric phenotype: A meta-analysis

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 12, 2013, Pages 1431-1441

  Matos, Joana I ^a   De Sousa, Henrique A C ^a   Marcos Pinto, Ricardo ^a,b,c   Dinis Ribeiro, Mário ^a,d  

^a CIDES   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Institute of Biomedical Sciences Abel Salazar   (Portugal)

^d PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

CagA protein; gastric adenocarcinoma; Helicobacter pylori; peptic ulcer disease; stomach neoplasms; VacA protein

Indexed keywords

CAGA PROTEIN; VACUOLATING TOXIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; CANCER RISK; GASTRITIS; GENE EXPRESSION; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; PEPTIC ULCER; PHENOTYPE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH LESION; SYSTEMATIC REVIEW;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; GASTRITIS; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PHENOTYPE; RISK ASSESSMENT; STOMACH NEOPLASMS; VIRULENCE;

EID: 84887037149     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328364b53e     Document Type: Article

References (109)

1. Jang S, Jones KR, Olsen CH, Joo YM, Yoo Y, Chung I, et al. Epidemiological link between gastric disease and polymorphisms in VacA and CagA. J Clin Microbiol 2010; 48:559-567.
2. Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001; 158:647-654.
3. Siavoshi F, Malekzadeh R, Daneshmand M, Ashktorab H. Helicobacter pylori endemic and gastric disease. Dig Dis Sci 2005; 50:2075-2080.
4. Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001; 107:767-773.
5. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori IceA, CagA, and VacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999; 37:2274-2279.
6. Wen S, Moss SF. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 2009; 282:1-8.
7. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4:688-694.
8. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama M. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA 2002; 99:14428-14433.
9. Zhang Y, Argent RH, Letley DP, Thomas RJ, Atherton JC. Tyrosine phosphorylation of CagA from Chinese Helicobacter pylori isolates in AGS gastric epithelial cells. J Clin Microbiol 2005; 43:786-790.
10. Azuma T, Yamazaki S, Yamakawa A, Ohtani M, Muramatsu A, Suto H, et al. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis 2004; 189:820-827.
11. Naito M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S, et al. Influence of EPIYA-repeat polymorphism on the phosphorylationdependent biological activity of Helicobacter pylori CagA. Gastroenterology 2006; 130:1181-1190.
12. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004; 113:321-333.
13. Hirata Y, Maeda S, Mitsuno Y, Tateishi K, Yanai A, Akanuma M, et al. Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology 2002; 123:1962-1971.
14. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci USA 2004; 101:7727-7732.
15. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007; 133:926-936.
16. Marcos-Pinto R, Carneiro F, Dinis-Ribeiro M, Wen X, Lopes C, Figueiredo C, et al. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther 2012; 35:1451-1459.
17. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, et al. An inverse relation between CagA + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58:588-590.
18. Rugge M, Cassaro GM, Shiao YH, Russo V, Leandro G, Avellini C, et al. Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer 1999; 85: 2506-2511.
19. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-2115.
20. Basso D, Navaglia F, Brigato L, Piva MG, Toma A, Greco E, et al. Analysis of Helicobacter pylori VacA and CagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut 1998; 43:182-186.
21. Miehlke S, Kirsch C, Agha-Amiri K, Gunther T, Lehn N, Malfertheiner P, et al. The Helicobacter pylori VacA s1, m1 genotype and CagA is associated with gastric carcinoma in Germany. Int J Cancer 2000; 87:322-327.
22. Gwack J, Shin A, Kim CS, Ko KP, Kim Y, Jun JK, et al. CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer 2006; 95:639-641.
23. Nomura AMY, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser MJ. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis 2002; 186:1138-1144.
24. Matsukura N, Onda M, Kato S, Hasegawa H, Okawa K, Shirakawa T, et al. Cytotoxin genes of Helicobacter pylori in chronic gastritis, gastroduodenal ulcer and gastric cancer: an age and gender matched case-control study. Cancer Res 1997; 88:532-536.
25. Shimoyama T, Yoshimura T, Mikami T, Fukuda S, Crabtree JE, Munakata A. Evaluation of Helicobacter pylori VacA genotype in Japanese patients with gastric cancer. J Clin Pathol 1998; 51:299-301.
26. Sicinschi LA, Lopez-Carrillo L, Camargo MC, Correa P, Sierra RA, Henry RR, et al. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and-10 genes. Int J Cancer 2006; 118:649-657.
27. Garza-Gonzá lez E, Bosques-Padilla FJ, Pé rez-Pé rez GI, Flores-Gutié rrez JP, Tijerina-Menchaca R. Association of gastric cancer, HLA-DQA1, and infection with Helicobacter pylori CagA and VacA in a Mexican population. J Gastroenterol 2004; 39:1138-1142.
28. Louw JA, Kidd MS, Kummer GF, Taylor K, Kotze U, Hanslo D. The relationship between Helicobacter pylori infection, the virulence genotypes of the infecting strain and gastric cancer in the African setting. Helicobacter 2001; 6:268-273.
29. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40:297-301.
30. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94:1680-1687.
31. Figueiredo C, Van Doorn L-J, Nogueira C, Soares JM, Pinho C, Figueira P, et al. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 2001; 2:128-135.
32. Basso D, Zamboon CF, Letley DP, Stranges A, Marchet A, Rhead JL, et al. Clinical relevance of Helicobacter pylori CagA and VacA gene polymorphisms. Gastroenterology 2008; 135:91-99.
33. Ribeiro ML, Godoy APO, Benvengo YHB, Mendonça S, Pedrazzoli J Jr. Clinical relevance of the CagA, VacA and IceA genotypes of Helicobacter pylori in Brazilian clinical isolates. Immunol Med Microbiol 2003; 36: 181-185.
34. Proença Mó dena J, Lopes Sales A, Olszanski Acrani G, Russo R, Vilela Ribeiro M, Fukuhara Y, et al. Association between Helicobacter pylori genotypes and gastric disorders in relation to the Cag pathogenicity island. Diagn Microbiol Infect Dis 2007; 59:7-16.
35. Gatti LL, Modena J, Payao S, Smith M, Fukuhara Y, Mó dena J, et al. Prevalence of Helicobacter pylori CagA, IceA and BabA2 alleles in Brazilian patients with upper gastrointestinal diseases. Acta Trop 2006; 100:232-240.
36. Van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, De Boer W, Quint W. Clinical relevance of the CagA, VacA, and IceA status of Helicobacter pylori. Gastroenterology 1998; 115:58-66.
37. Li L, Graham DY, Gutierrez O, Kim JG, Genta RM, El-Zimaity HMT, Go MF. Genomic fingerprinting and genotyping of Helicobacter pylori strains from patients with duodenal ulcer or gastric cancer from different geographic regions. Dig Dis Sci 2002; 47:2512-2518.
38. Ashou AAR, Magalhaes PP, Mendes EN, Collares GB, de Gusmao VR, Queiroz DMM, et al. Distribution of VacA genotypes in Helicobacter pylori strains isolated from Brazilian adult patients with gastritis, duodenal ulcer or gastric carcinoma. Immunol Med Microbiol 2002; 33:173-178.
39. Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, et al. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006; 55:775-781.
40. Evans DG, Queiroz DMM, Mendes EN, Evans DJ. Helicobacter pylori CagA status and s and m alleles of VacA in isolates from individuals with a variety of H. pylori-associated gastric diseases. Journal Clin Microbiol 1998; 36:3435-3437.
41. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relationship of VacA genotypes of Helicobacter pylori to CagA status, cytotoxin production, and clinical outcome. Helicobacter 1998; 3:241-253.
42. Lin HJ, Perng CL, Lo WC,Wu CW, Tseng GY, Li AFY, et al. Helicobacter pylori CagA, IceA and VacA genotypes in patients with gastric cancer in Taiwan. World J Gastroenterol 2004; 10:2493-2497.
43. Perng CL, Lin HJ, Facg , Sun IC, Tseng GY. Helicobacter pylori CagA, IceA and VacA status in Taiwanese patients with peptic ulcer and gastritis. J Gastroenterol Hepatol 2003; 18:1244-1249.
44. Perng CL, Lin HJ, Lo WC, Tseng GY, Sun IC, Ou YH. Genotypes of Helicobacter pylori in patients with peptic ulcer bleeding. World J Gastroenterol 2004; 10:602-605.
45. Vilaichone RK, Mahachai V, Tumwasorn S,Wu JY, Graham DY, Yamaoka Y. Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori CagA genotype. Scand J Gastroenterol 2005; 40:530-539.
46. Wang HJ, Kuo CH, Yeh AAM, Chang PCL, Wang WC. Vacuolating toxin production in clinical isolates of Helicobacter pylori with different VacA genotypes. J Infect Dis 1998; 178:207-212.
47. Kima YS, Kima N, Kimc JM, Kima MS, Parka JH, Leea MK, et al. Helicobacter pylori genotyping findings from multiple cultured isolates and mucosal biopsy specimens: strain diversities of Helicobacter pylori isolates in individual hosts. Eur J Gastroenterol Hepatol 2009; 21:522-528.
48. Con SA, Takeuchi H, Valer?́n AL, Con-Wong R, Con-Chin GR, Con-Chin VG, et al. Diversity of Helicobacter pylori CagA and VacA genes in Costa Rica: its relationship with atrophic gastritis and gastric cancer. Helicobacter 2007; 12:547-552.
49. Paniagua GL, Monroy E, Rodr?́guez R, Arroniz S, Rodr?́guez C, Cortés JL, et al. Frequency of VacA, CagA and BabA2 virulence markers in Helicobacter pylori strains isolated from Mexican patients with chronic gastritis. Ann Clin Microbiol Antimicrob 2009; 8:1-6.
50. Gonzá lez-Valencia G, Atherton JC, Muno z O, Dehesa M, Madrazo-de la Garza A, Torres J. Helicobacter pylori VacA and CagA genotypes in Mexican adults and children. J Infect Dis 2000; 182:1450-1454.
51. Kidd M, Lastovica AJ, Atherton JC, Louw JA. Heterogeneity in the Helicobacter pylori VacA and CagA genes: association with gastroduodenal disease in South Africa? Gut 1999; 45:499-502.
52. Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi AR, Saberifiroozi M. Association of H pylori CagA and VacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol 2006; 12: 5205-5210.
53. Douraghi M, Talebkhan Y, Zeraati H, Mohammadi M. Cooperative genotyping for Helicobacter pylori virulence determinants strengthens the predictive value of gastric cancer risk assessment. Dig Liver Dis 2010; 42:662-664.
54. Jafari F, Shokrzadeh L, Dabiri H, Baghaei K, Yamaoka Y, Zojaji H, et al. VacA genotypes of Helicobacter pylori in relation to CagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis 2008; 61:290-293.
55. Dabiri H, Maleknejad P, Yamaoka Y, Feizabadi MM, Jafari F, Rezadehbashi M, et al. Distribution of Helicobacter pylori CagA, CagE, OipA and VacA in different major ethnic groups in Tehran, Iran. J Gastroenterol Hepatol 2009; 24:1380-1386.
56. Saribasak H, Salih BA, Yamaoka Y, Sander E. Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol 2004; 42:1648-1651.
57. Warburton VJ, Everett S, Mapston NP, Axon ATR, Hawkey P, Dixon MF. Clinical and histological associations of CagA and VacA genotypes in Helicobacter pylori gastritis. Clin Pathol 1998; 51:55-61.
58. Hö cker M, Hohenberger P. Helicobacter pylori virulence factors-one part of a big picture. Lancet 2003; 362:1231-1233, 11.
59. Yamaoka Y. Increasing evidence of the role of Helicobacter pylori SabA in the pathogenesis of gastroduodenal disease. J Infect Dev Ctries 2008; 2:174-181.
60. Correa P. New strategies for the prevention of gastric cancer: Helicobacter pylori and genetic susceptibility. J Surg Oncol 2005; 90:134-138, discussion 138.
61. Cover TL. Role of Helicobacter pylori outer membrane proteins in gastroduodenal disease. J Infect Dis 2006; 194:1343-1345.
62. Sugimoto M, Yamaoka Y. Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy. Arch Immunol Ther Exp (Warsz) 2009; 57:45-56.
63. Valmaseda Pé rez T, Gisbert JP, PajaresGarc?́a JM. Geographic differences and the role of CagA gene in gastroduodenal diseases associated with Helicobacter pylori infection. Rev Esp Enferm Dig 2001; 93:471-480.
64. Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 2008; 47:1077-1083.
65. Sugimoto M, Zali MR, Yamaoka Y. The association of VacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin Microbiol Infect Dis 2009; 28:1227-1236.
66. Sugimoto M, Yamaoka Y. The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clin Microbiol Infect 2009; 15:835-842.
67. Zhou J, Zhang J, Xu C, He L. CagA genotype and variants in Chinese Helicobacter pylori strains and relationship to gastroduodenal diseases. J Med Microbiol 2004; 53:231-235.
68. Kidd M, Lastovica AJ, Atherton JC, Louw JA. Conservation of the Cag pathogenicity island is associated with VacA alleles and gastroduodenal disease in South African Helicobacter pylori isolates. Gut 2001; 49:11-17.
69. Azuma T, Yamakawa A, Yamazaki S, Fukuta K, Ohtani M, Ito Y, et al. Correlation between variation of the 30 region of the CagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 2002; 186:1621-1630.
70. Azuma T, Yamakawa A, Yamazaki S, Ohtani M, Ito Y, Muramatsu A, et al. Distinct diversity of the Cag pathogenicity island among Helicobacter pylori strains in Japan. J Clin Microbiol 2004; 42:2508-2517.
71. Jones KR, Joo YM, Jang S, Yoo YJ, Lee HS, Chung IS, et al. Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J Clin Microbiol 2009; 47:959-968.
72. Ló pez-Vidal Y, Ponce-de-Leó n S, Castillo-Rojas G, Barreto-Zú niga R, Torre-Delgadillo A. High diversity of VacA and CagA Helicobacter pylori genotypes in patients with and without gastric cancer. PloS One 2008; 3:e3849.
73. Alves M, Lima V, Ferrasi A, Rodrigues M, Pardini M, Rabenhorst S. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas. APMIS 2010; 118:297-307.
74. Filho E, Alves M, Lima V, Rabenhorst S. MTHFR C677T polymorphism and differential methylation status in gastric cancer: an association with Helicobacter pylori infection. Virchows Arch 2010; 457:627-633.
75. Schneider BG, Peng DF, Camargo MC, Piazuelo MB, Sicinschi LA, Mera R, et al. Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer 2009; 127:2588-2597.
76. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004; 53:1082-1089.
77. Gong YH, Wang Y, Yuan Y. Distribution of Helicobacter pylori in north China. World J Gastroenterol 2005; 11:3523-3527.
78. Salama NR, Gonzalez-Valencia G, Deatherage B, Aviles-Jimenez F, Atherton JC, Graham DY, Torres J. Genetic analysis of Helicobacter pylori strain populations colonizing the stomach at different times postinfection. J Bacteriol 2007; 189:3834-3845.
79. Lee JH, Choe YH, Jeon BH, Oh YJ, Kim JJ, Rhee JC, et al. Genotypes of the Helicobacter pylori VacA signal sequence differ with age in Korea. Helicobacter 2004; 9:54-58.
80. Nimri LF, Matalka I, Hani KB, Ibrahim M. Helicobacter pylori genotypes identified in gastric biopsy specimens from Jordanian patients. BMC Gastroenterol 2006; 6:27.
81. Rad R, Gerhard M, Lang R, Schoniger M, Rosch T, Schepp W, et al. The Helicobacter pylori blood group antigen-binding adhesion facilitates bacterial colonization and augments a nonspecific immune response. J Immunol 2002; 168:3033-3041.
82. Weel JFL, van der Hulst RWM, Gerrits Y, Roorda P, Feller M, Dankert J, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 1996; 173:1171-1175.
83. Erzin Y, Koksal V, Altun S, Dobrucali A, Aslan M, Erdamar S, et al. Prevalence of Helicobacter pylori VacA, CagA, CagE, IceA, BabA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter 2006; 11:574-580.
84. Vilaichone RK, Mahachai V, Tumwasorn S,Wu JY, Graham DY, Yamaoka Y. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter 2004; 9:453-459.
85. Semino-Mora C, Doi SQ, Marty A, Simko V, Carlstedt I, Dubois A. Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis 2003; 187:1165-1177.
86. Plummer M, van Doorn LJ, Franceschi S, Kleter B, Canzian F, Vivas J, et al. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst 2007; 99:1328-1334.
87. Con SA, Takeuchi H, Con-Chin GR, Con-Chin VG, Yasuda N, Con-Wong R. Role of bacterial and genetic factors in gastric cancer in Costa Rica. World J Gastroenterol 2009; 15:211-218.
88. Yu J, Leung WK, Go MYY, Chan MCW, To KF, Ng EKW, et al. Relationship between Helicobacter pylori BabA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 2002; 51:480-484.
89. Han YH, Liu WZ, Zhu HY, Xiao SD. Clinical relevance of IceA and BabA2 genotypes of Helicobacter pylori in a Shanghai population. Chin J Dig Dis 2004; 5:181-185.
90. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16:3-15.
91. Forsyth MH, Atherton JC, Blaser MJ, Cover TL. Heterogeneity in levels of vacuolating cytotoxin gene (VacA) transcription among Helicobacter pylori strains. Infect Immun 1998; 66:3088-3094.
92. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest 1997; 100:759-762.
93. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10:720-741.
94. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49:347-353.
95. Huang JQ, Zheng GF, Summanac K, Jan Irvine E, Hunt Richard H. Metaanalysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology 2003; 125:1636-1644.
96. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114:1169-1179.
97. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999; 94:2373-2379.
98. Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999; 13:851-856.
99. Kikuchi S, Crabtree JE, Forman D, Kurosawa M. Association between infections with CagA-positive or-negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Am J Gastroenterol 1999; 94:3455-3459.
100. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Munakata A, Crabtree JE. CagA seropositivity associated with development of gastric cancer in a Japanese population. J Clin Pathol 1998; 51:225-228.
101. Maeda S, Yoshida H, Ogura K, Yamaji Y, Ikenoue T, Mitsushima T, et al. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs. Cancer 2000; 88:1530-1535.
102. Hanzell SL, Hennessy WB, Borody TJ, Carrick J, Ralston M, Brady L, Lee A. Campylobacter pyloridis gastritis II: distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol 1987; 82:297-301.
103. Robey-Cafferty SS, Ro JY, Cleary KR. The prevalence of Campylobacter pylori in gastric biopsies from cancer patients. Mod Pathol 1989; 2: 473-476.
104. Endo S, Ohkusa T, Saito Y, Fujiki K, Okayasu I, Sato C. Detection of Helicobacter pylori infection in early stage gastric cancer. A comparison between intestinal-and diffuse-type gastric adenocarcinomas. Cancer 1995; 75:2203-2208.
105. Lucia Caruso M, Fucci L. Histological identification of Helicobacter pylori in early and advanced gastric cancer. J Clin Gastroenterol 1990; 12:601-602.
106. Craanen ME, Blok P, Dekker W, Tytgat GNJ. Helicobacter pylori and early gastric cancer. Gut 1994; 35:1372-1374.
107. Lin JT,Wang LY,Wang JT,Wang TH, Yang CS, Chen CJ. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res 1995; 15:603-606.
108. Webb PM, Yu MC, Forman D, Henderson BE, Newell DG, Yuan JM, et al. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int J Cancer 1996; 67:603-607.
109. Dinis-Ribeiro M, Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, et al. European Society of Gastrointestinal Endoscopy; European Helicobacter Study Group; European Society of Pathology; Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44:74-94.